Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids

癌症研究 卡铂 紫杉醇 PARP抑制剂 细胞毒性 顺铂 药理学 分子生物学 癌症 医学 生物 化疗 内科学 聚ADP核糖聚合酶 聚合酶 体外 DNA 生物化学
作者
Beverly A. Teicher,Thomas S. Dexheimer,Li Chen,Thomas Silvers,Eric M. Jones,Nathan P. Coussens,Joseph P. Eder,James H. Doroshow
出处
期刊:Experimental and Molecular Pathology [Elsevier BV]
卷期号:143: 104978-104978 被引量:1
标识
DOI:10.1016/j.yexmp.2025.104978
摘要

The potential of novobiocin, recently identified to be a DNA POLѲ inhibitor, to augment cancer chemotherapy was explored in the late 1980s and early 1990s in tumor cells, tumor-bearing mice and in Phase 1 clinical trial in combination with cyclophosphamide or cisplatin. Genetic alterations which may increase or decrease POLѲ inhibitor effects have been elucidated. Thirty patient-derived tumor cell lines with known BRCA, ATM, ATR, POLѲ, XRCC1, PALB2, PARP1, LIG3 alterations as well as know gLOH% and MSI status were screened in a mct-spheroid assay (tumor cells, endothelial cells, mesenchymal stem cells) with a POLѲ inhibitor, novobiocin, ART-558, and RP6685, alone or in simultaneous combination with a FDA-approved or investigational anticancer small molecule with a 7-day exposure and a CellTiter-Glo 3D luminescence endpoint. As single agents, the POLѲ inhibitors had little or no cytotoxicity. In simultaneous combination with ART-558, talazoparib produced greater-than-additive cytotoxicity at the highest concentrations of the POLѲ inhibitors in the 922,993-354-T-J3-PDC endometrial serous carcinoma mct-spheroids. Activity of the Chk1/2 inhibitor prexasertib was potentiated by either ART-558 or RP6685 in the 922,993-354-T-J3 mct-spheroids. The combination of POLѲ inhibitors ART-558 and RP6685, and the Chk1/2 inhibitor prexasertib produced up to 1 log increase in cytotoxicity in the 922,993-354-T-J3 mct-spheroids. Regions of potentiation were evident in the 922,993-354-T-J3-PDC endometrial carcinoma survival surface plots at the highest concentration of paclitaxel tested, while regions of potentiation were evident in the paclitaxel mid-concentrations of the 299,254-011-R-J1-PDC melanoma mct-spheroids survival surface plots as determined by the Bliss independence calculation. DNA POLѲ is recruited to DNA double-strand breaks as a component of repair. POLѲ allosteric inhibitors, novobiocin, ART558 and RP-6685, have entered clinical trial. The current study explores the cytotoxicity of POLѲ inhibitors in combination with anticancer drugs and investigational agents in patient-derived cell lines grown as mct-spheroids.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
nglone发布了新的文献求助10
刚刚
ku发布了新的文献求助10
1秒前
1秒前
羊咩咩完成签到,获得积分10
1秒前
2秒前
2秒前
Lny发布了新的文献求助10
2秒前
金山时雨完成签到,获得积分10
3秒前
3秒前
3秒前
Nole的应助被哈哈哈采纳,获得10
3秒前
4秒前
羊咩咩发布了新的文献求助20
5秒前
5秒前
hai完成签到,获得积分10
6秒前
6秒前
无极微光的应助被保持客气采纳,获得30
6秒前
核桃发布了新的文献求助10
6秒前
水天需发布了新的文献求助30
6秒前
6秒前
zoe完成签到 ,获得积分10
7秒前
阔达幼珊完成签到,获得积分10
8秒前
眼睛大的可乐完成签到,获得积分10
8秒前
can发布了新的文献求助10
8秒前
hai发布了新的文献求助10
9秒前
9秒前
10秒前
10秒前
11秒前
独角戏完成签到,获得积分10
11秒前
WWT发布了新的文献求助10
11秒前
11秒前
端庄问蕊发布了新的文献求助10
12秒前
John的应助被冷傲的不愁采纳,获得10
13秒前
13秒前
正直道消发布了新的文献求助10
13秒前
vitrimer发布了新的文献求助10
13秒前
北林完成签到,获得积分10
13秒前
14秒前
埋头赶路完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183894
求助须知:如何正确求助?哪些是违规求助? 9573067
关于积分的说明 21829226
捐赠科研通 7780983
什么是DOI,文献DOI怎么找? 3434150
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480648